DEPO Financial Facts

Interest and other income: 519K
Total costs and expenses: 33.13M
See Full Income Statement

Accounts receivable: 11.45M
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY: 508.65M
See Full Balance Sheet

DepoMed Inc. (DEPO) Earnings

  |   Expand Research on DEPO
Next EPS Date 5/9/14 *Est. EPS Growth Rate +1,128.6% *Last Qtr.
Average EPS % Beat Rate +138.3% Revenue Growth Rate -29.4% *Last Qtr.
Average % Move 1-Wk after EPS +4.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/6/14 Q413 $0.72-$0.21 +$0.93$18.79M$19.06M = -4.7% Details
11/5/13 Q313 $0.11$0.07 +$0.04$37.5M$35.55M = +73.2% Details
8/7/13 Q213 $0.01-$0.05 +$0.06$30M$29.87M = +99.8% Details
5/8/13 Q113 -$0.10-$0.06 -$0.04$26.2M$28.93M = +131.5% Details
2/20/13 Q412 -$0.07-$0.11 +$0.04$26.6M$26.48M = +90.9% Details
11/5/12 Q312 -$0.03-$0.09 +$0.06$33.3M$30.47M N/A +125.4% Details
8/2/12 Q212 -$0.28-$0.21 -$0.07$14.1M$16.73M N/A +135.3% Details
5/8/12 Q112 -$0.16-$0.24 +$0.08$16.8M$12.88M N/A +125.4% Details